Carboplatin and Paclitaxel With or Without Atezolizumab Before Surgery in Treating Patients With Newly Diagnosed, Stage II-III Triple-Negative Breast Cancer

NCT02883062 · clinicaltrials.gov ↗

PHASE2

Phase

ACTIVE_NOT_RECRUITING

Status

67

Enrollment

NIH

Sponsor class

Conditions

Invasive Breast Carcinoma
Stage II Breast Cancer AJCC v6 and v7
Stage III Breast Cancer AJCC v7
Triple-Negative Breast Carcinoma

Interventions

DRUG: Atezolizumab
PROCEDURE: Biospecimen Collection
DRUG: Carboplatin
PROCEDURE: Lumpectomy
PROCEDURE: Mastectomy
DRUG: Paclitaxel

Sponsor

National Cancer Institute (NCI)